Homogeneous time-resolved fluorescence resonance energy transfer (TR-FRET) assays represent a highly sensitive and robust high-throughput screening (HTS) method for the quantification of kinase activity. Traditional TR-FRET kinase assays detect the phosphorylation of an exogenous substrate. The authors describe the development and optimization of a TR-FRET technique that measures the autophosphorylation of vascular endothelial growth factor receptor 2 (VEGFR-2) kinase and extend its applicability to a variety of other kinases. The VEGFR-2 assay demonstrated dose-dependent inhibition by compounds known to modulate the catalytic activity of this receptor. In addition, kinetic analysis of a previously characterized VEGFR-2 inhibitor was performed using the method, and results were consistent with those obtained using a different assay format. Because of the known involvement of VEGFR-2 in angiogenesis, this assay should facilitate HTS for antiangiogenic agents. In addition, this general technique should have utility for the screening for inhibitors of kinases as potential therapeutic agents for many other disease indications. (Journal of Biomolecular Screening 2003:447-452) 
INTRODUCTION
P rotein kinases are well recognized as important targets for the development of therapeutic agents for the treatment of a variety of diseases. 1 Numerous high-throughput assay formats are available for the measurement of kinase activity, including traditional enzyme-linked immunosorbent assay (ELISA) methods, 2 scintillation proximity assay (SPA), 3 fluorescence polarization (FP), 4 and time-resolved fluorescence resonance energy transfer (TR-FRET). 5 TR-FRET assays offer advantages over many other techniques in that they are homogeneous, easily automated, and nonradioactive, and they can be scaled up to a 384-or 1536-well format. In addition, the time-resolved measurement enables the screening of libraries containing fluorescent molecules, as interfering background fluorescence is eliminated. 6 Angiogenesis is the physiological process by which new capillaries form from existing blood vessels. Enhanced angiogenesis is associated with a variety of disease states, including cancer. 7 Vascular endothelial growth factor (VEGF) is known to play a key role in this process, 8 and therefore much effort has focused on blocking the action of VEGF for potential cancer therapies. In fact, a number of agents that interfere with VEGF-mediated signaling are currently in clinical trials. 9, 10 Because the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR-2), an endothelial cell-specific receptor for VEGF, 11 is required for subsequent signal transduction events, the use of small molecules to inhibit the catalytic activity of this receptor represents a viable strategy for angiogenesis inhibition. 9 Recent intense effort throughout the industry has resulted in the identification of a number of molecules that have activity against VEGFR-2 kinase. 12 The goal of this study was to develop a homogeneous TR-FRET kinase assay for VEGFR-2 in an attempt to identify small molecules that modulate angiogenesis. However, during the process of kinase substrate identification and characterization, it was determined that the assay unexpectedly detects autophosphorylation of the receptor, suggesting that it could be used as a general assay format for all kinases that undergo autophosphorylation. Here, we describe the development and characterization of this TR-FRET-based autophosphorylation assay for VEGFR-2, its validation with known inhibitors, and the feasibility of using this novel assay type for other known tyrosine kinases.
MATERIALS AND METHODS

Kinases and inhibitors
The cytoplasmic domains of mouse VEGFR-2 (Flk1), human fibroblast growth factor receptor 1 (FGFR-1), Met, epidermal growth factor receptor (EGFR), platelet-derived growth factor receptor β (PDGFR-β), and the kinase domain of human Src were expressed as N-terminal glutathione S-transferase (GST) fusion proteins in Sf9 insect cells using baculovirus systems. They were purified with Glutathione Sepharose 4 Fast Flow (Amersham Pharmacia) under the manufacturer's recommendations. Syntheses of SU11248, SU101, and SU6656 were described previously. [13] [14] [15] Staurosporine was from Sigma.
TR-FRET kinase reactions
For homogeneous TR-FRET assays using VEGFR-2, 1 nM kinase was added to 6 µM adenosine triphosphate (ATP) and 0.12 µM of either N-terminal biotinylated KY-tide (KYKKYKKKYKKKKYKYK) or KF-tide (KFKKFKKKFKKKKFKFK) in a reaction buffer composed of 50 mM HEPES (pH 7.4), 1 mM MnCl 2 , 0.01% bovine serum albumin (BSA), and 1 mM dithiothreitol (DTT) in 50 µL total volume. Reactions were terminated by the addition of 20 µL 90 mM EDTA. Eu-W1024-labeled antiphosphotyrosine PY20 and Streptavidin: SureLight-Allophycocyanin (APC; Perkin Elmer Life Sciences) were diluted in Tris-buffered saline (TBS) containing 0.02% BSA and 0.1% Tween-20 and added to a final concentration of 0.5 nM and 1.6 nM, respectively. After incubation for at least 10 min, samples were excited at 340 nM, and emissions were read at 665 nM using an LJL Analyst (LJL Biosystems). For inhibitor testing, compounds were added to the reaction in a final concentration of 1% DMSO, and the DMSO concentration of the controls was adjusted accordingly. For the TR-FRET assays involving kinases other than VEGFR-2, reactions were performed in the same manner except that the concentration of ATP was 100 µM, KY-tide 1 µM, and kinase 2 to 5 nM. All reactions were performed in a 96-well plate format. 32 
P kinase reaction
For the 32 P phosphorylation reaction, VEGFR-2 and KY-tide were incubated exactly as in the TR-FRET kinase assay but with the addition of 10 µCi γ 32 P ATP (Perkin Elmer Life Sciences). Then, 25% of the reaction was subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) analysis on a 4% to 20% gradient gel. The gel was dried and directly exposed to film overnight.
Kinetic analysis
K m experiments for ATP were performed using the above stated TR-FRET reaction conditions at various ATP concentrations and a fixed KY-tide concentration of 1 µM. For KY-tide, comparable analysis was denoted as an apparent K m (K mApp ) study because the peptide is not a substrate for the kinase. For these experiments, the concentration of peptide was varied, and a fixed ATP concentration of 100 µM was used. Velocities (rates) were expressed as the increase in TR-FRET counts per minute of reaction within the linear reaction time. The data were plotted using GraphPad Prism (GraphPad Software, Inc.), and curves were fit to the Michaelis-Menten equation. The SU11248 K i experiment was conducted in the same manner as the ATP K m but at various inhibitor concentrations. The K i was determined by graphical analysis of the plot of the slopes from the double reciprocal plot versus inhibitor concentration.
RESULTS
VEGFR-2 kinase substrate identification and characterization
The first step in VEGFR-2 assay development involved the identification of a suitable substrate for kinase phosphorylation. To this end, biotinylated peptides based on synthetic polymer sequences known to be substrates of tyrosine kinases in ELISA assays (e.g., Poly(Glu,Tyr) and Poly(Lys,Tyr)) were tested for their ability to act as substrates for VEGFR-2 in a homogeneous TR-FRET assay format. Use of one, KY-tide (biotin-KYKKYKKKYKKKKYKYK), resulted in a signal-to-background ratio of > 10 in initial testing. Further experiments showed that the increase in signal was time dependent and required the addition of ATP, KY-tide, kinase, and metal cation ( Fig. 1 ).
To ascertain whether KY-tide was acting as a direct phosphorylation substrate for VEGFR-2, a reaction was run without peptide, and then the peptide was added after the kinase reaction had been stopped. Surprisingly, a similar signal was observed whether KY-tide was present in the kinase reaction or added afterward (data not shown). This indicates that the generation of signal was independent of peptide phosphorylation and suggests its dependence on a VEGFR-2 autophosphorylation event.
Two approaches were taken to further assess whether VEGFR-2 was phosphorylating KY-tide itself, or both in the kinase reaction: (1) use of a TR-FRET reaction with VEGFR-2 and KF-tide (biotin-KFKKFKKKFKKKKFKFK), a peptide similar in composition to KY-tide but theoretically unable to act as a substrate for tyrosine kinases, and (2) use of a 32 P phosphorylation reaction with the kinase and KY-tide followed by SDS-PAGE analysis. Results of the KF-tide reaction, shown in Figure 2 , strongly suggest that the signal in the TR-FRET readout is heavily dependent on kinase autophosphorylation, as a time-dependent increase in signal was obtained using KF-tide. However, the intensity of the KF-tide signal was only approximately 70% of that with KY-tide, indicating that there is some phosphorylation of peptide or that KF-tide has a lower affinity for VEGFR-2 than does KY-tide. The radioactive labeling experiment clearly shows that VEGFR-2 is indeed mainly phosphorylating itself in the kinase reaction, with a very minor component of transphosphorylation of peptide ( Fig. 3) .
TR-FRET assay optimization
To optimize conditions for the kinase reaction, buffer containing differing amounts of salt (NaCl or KCl) and/or differing metal cations (Mg 2+ , Mn 2+ , or both) were tested. Optimal buffer conditions were found to be 50 mM HEPES (pH 7.4), 1 mM MnCl 2 , 0.01% BSA, and 1 mM DTT. These conditions were then used to determine the apparent K m values for ATP and KY-tide in the reaction. Phosphorylation was performed at various concentrations of either ATP or peptide, with the other component present in a saturating amount. Plots of the reaction rate versus ATP or peptide concentration are shown in Figure 4 . The K m value for ATP was deter-mined to be 3.2 ± 0.6 µM, and K mApp for KY-tide was 0.060 ± 0.025 µM. Based on these values, 6 µM ATP and 0.12 µM KY-tide were chosen for compound testing. Under these conditions, the reaction was linear for approximately 4 min, and the signal to background was about 15 using 5 ng of kinase per well (1 nM). Z′ factors with the assay typically ranged from 0.6 to 0.85.
Reagent stability is a concern when one processes large numbers of plates in a screening batch. Therefore, the stability of the diluted kinase, ATP, peptide, and TR-FRET detection reagents was tested along with the stability of the signal in the reaction after addition of detection reagents. No loss of activity was seen following dilution of kinase, ATP, and peptide for at least 40 min, diluted TR-FRET reagents for at least 6 h, and signal for at least 2 h.
Assay validation and general applicability
To assess the utility of this assay for screening, a known inhibitor of VEGFR-2 kinase, SU11248, 16 was tested along with staurosporine, a more general kinase inhibitor. As shown by the graph in Figure 5 , SU11248 inhibited enzymatic activity in a dosedependent manner. The IC 50 for this compound was determined to be 0.037 ± 0.019 µM. Staurosporine also inhibited the kinase, albeit at a higher concentration (Table 1) . Notably, 2 compounds that are not expected to inhibit VEGFR-2, SU101 14 and SU6656, 15 both demonstrated IC 50 s of > 10 µM in the assay.
To determine whether this assay can be used for kinetic characterization of inhibitors, a K i study was done with SU11248. The kinase reaction was performed at various ATP concentrations in the presence of differing amounts of SU11248, and the effect of compound on reaction rates was assessed. A double reciprocal plot of the results of this analysis is presented in Figure 6 . The curves generally converge on the y-axis, indicating that the inhibition by this compound is predominantly competitive with respect to ATP. The K i value was determined to be 0.010 ± 0.004 µM. This is in ac- cordance with the previously reported K i of 0.009 ± 0.002 µM for SU11248 against VEGFR-2, which was generated using an ELISA assay with Poly(Glu,Tyr) as the substrate. 16 Because KY-tide was determined to be, in effect, a reagent that enables detection of kinase autophosphorylation, this raised the possibility that it could be used to measure autophosphorylation events of other kinases in addition to VEGFR-2. To explore this, 5 other tyrosine kinases were tested in catalytic reactions with KYtide in the TR-FRET format. Each yielded a signal in the reaction ( Table 2) , indicating that the utility of KY-tide as an autophosphorylation detection reagent is not limited to VEGFR-2 but rather is applicable to other tyrosine kinases as well.
DISCUSSION
We have introduced a novel TR-FRET screening technique that measures autophosphorylation of kinases and have applied it to VEGFR-2. The assay yields high Z′ factors and is robust, homogeneous, and therefore very amenable to automation. Also, because it is based on TR-FRET technology, the method can easily be scaled up to 384-or 1536-well formats. The reagents in the assay are stable for a long period of time, enabling the processing of large batches of plates. Compounds that are known VEGFR-2 kinase inhibitors inhibit in a dose-dependent manner in this assay. Furthermore, the assay is useful for kinetic characterization of compounds, as demonstrated by the K i determination of a known inhibitor, and results are consistent with those generated by Poly(Glu,Tyr) ELISA methods. Traditional TR-FRET kinase assays are based on the phosphorylation of biotinylated peptide or polymer substrates followed by addition of europium chelate (Eu)-labeled antiphosphotyrosine and streptavidin-labeled allophycocyanin (SA-APC). If the substrate is phosphorylated, Eu-antiphosphotyrosine is brought into close proximity to the SA-APC, which is bound to biotinylated substrate. A signal is generated when the Eu absorbs energy at 340 nM and transfers it to the APC, which emits at 665 nM. 5 This scheme is illustrated in Figure 7A .
The TR-FRET assay described here differs from the traditional method in that the biotinylated peptide (KY-tide) is not a substrate of the kinase but is hypothesized to be acting as a binding reagent that allows for detection of kinase autophosphorylation. This is illustrated by the fact that (1) generation of signal is dependent on catalytic activity of the enzyme, (2) a similar signal is obtained if the peptide is added before or after kinase reaction, (3) a majority of the signal is generated using a similar peptide that is unable to undergo phosphorylation, and (4) SDS-PAGE analysis of 32 Plabeled kinase reaction reveals a predominant kinase band and extremely faint peptide band. This novel TR-FRET kinase reaction scheme is presented in Figure 7B . It is not known whether KY-tide binds to the substrate-binding pocket of VEGFR-2 or nonspecifically to the kinase or GST tag, but the peptide seems to be very tightly bound, evidenced by the measured K mApp of 0.060 ± 0.025 µM.
Numerous kinase assays using the TR-FRET format have been described, 5, [17] [18] [19] [20] but each of these requires the phosphorylation of a suitable substrate. Use of the assay described here eliminates the need to find a substrate for a given kinase, provided that it undergoes autophosphorylation. This could be advantageous when the substrate specificity of a kinase is not known, for kinases that do not phosphorylate poly(Glu,Tyr), and in situations when it is desirable to measure a more biologically relevant event than phosphorylation of a synthetic polymer. In addition, even though the method was limited to 6 tyrosine kinases in this study, it can theoretically be applied to serine/threonine kinases that autophosphorylate, with the substitution of Eu-labeled antiphosphoserine or threonine for antiphosphotyrosine.
One potential disadvantage of this system is the fact that kinases often have multiple autophosphorylation sites, raising the possibility of different phosphorylation kinetics for the sites in the reaction. The cytoplasmic domain of human VEGFR-2 has been reported to have at least 4 21 but likely 5 or more phosphorylation sites. 22, 23 This potential complication did not seem to have an effect on the kinetics of the autophosphorylation reaction with respect to ATP K m , as shown by the fact that the velocity versus ATP curve fits well to the Michaelis-Menten equation (Fig. 4A) . However, the time course of VEGFR-2 activity (Fig. 1 ) does suggest that there may be more than 1 phosphorylation event being measured, as the rate appears to be biphasic. This difficulty can easily be overcome by ensuring that the kinase reaction is allowed to proceed only for the amount of time corresponding to the initial linear portion of the curve (in this case, approximately 4 min) to ensure that initial rates are being measured.
In summary, we have introduced a homogeneous TR-FRET assay that is generally useful for the measurement of VEGFR-2, vascular endothelial growth factor receptor 2; TR-FRET, time-resolved fluorescence resonance energy transfer; FGFR-1, fibroblast growth factor receptor 1; EGFR, epidermal growth factor receptor; PDGFR-β, platelet-derived growth factor receptor β. a. Counts obtained with the addition of EDTA prior to the kinase reaction. b. Counts obtained after 30-min kinase reaction. autophosphorylation of kinases and have validated it for screening for VEGFR-2 inhibitors. It is our intention to use the VEGFR-2 TR-FRET assay to discover small molecules that will be of use as angiogenesis inhibitors for the treatment of cancer and other disorders.
